home / stock / allo / allo short
Short Information | Allogene Therapeutics Inc. (NASDAQ:ALLO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 13,574,669 |
Total Actual Volume | 71,498,506 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 678,733 |
Average Short Percentage | 19.52% |
Is there a ALLO Short Squeeze or Breakout about to happen?
See the ALLO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $3.07 | $2.83 | $3.07 | $2.805 | 2,233,657 | 343,278 | 15.37% |
07-18-2024 | $3.38 | $3.05 | $3.5 | $2.91 | 4,728,850 | 718,155 | 15.19% |
07-17-2024 | $3.44 | $3.42 | $3.5 | $3.2888 | 4,024,547 | 611,144 | 15.19% |
07-16-2024 | $3 | $3.5 | $3.67 | $3 | 8,958,367 | 2,146,478 | 23.96% |
07-15-2024 | $2.78 | $2.98 | $3.1 | $2.74 | 3,646,757 | 756,494 | 20.74% |
07-12-2024 | $2.7 | $2.76 | $2.85 | $2.66 | 1,734,421 | 248,308 | 14.32% |
07-11-2024 | $2.53 | $2.68 | $2.73 | $2.465 | 3,178,478 | 337,992 | 10.63% |
07-10-2024 | $2.3 | $2.39 | $2.4 | $2.275 | 1,376,673 | 192,041 | 13.95% |
07-09-2024 | $2.22 | $2.3 | $2.32 | $2.195 | 2,820,614 | 336,094 | 11.92% |
07-08-2024 | $2.19 | $2.24 | $2.29 | $2.13 | 2,062,393 | 550,496 | 26.69% |
07-05-2024 | $2.1 | $2.12 | $2.13 | $2.01 | 2,298,847 | 635,995 | 27.67% |
07-03-2024 | $2.2 | $2.08 | $2.2 | $2.08 | 1,775,732 | 633,767 | 35.69% |
07-02-2024 | $2.29 | $2.16 | $2.29 | $2.125 | 3,053,360 | 840,037 | 27.51% |
07-01-2024 | $2.33 | $2.33 | $2.41 | $2.3 | 2,245,996 | 386,640 | 17.21% |
06-28-2024 | $2.44 | $2.33 | $2.445 | $2.27 | 3,585,124 | 402,398 | 11.22% |
06-27-2024 | $2.34 | $2.44 | $2.495 | $2.28 | 2,371,575 | 387,922 | 16.36% |
06-26-2024 | $2.39 | $2.34 | $2.4392 | $2.23 | 2,996,283 | 728,357 | 24.31% |
06-25-2024 | $2.6 | $2.4 | $2.6 | $2.39 | 3,973,965 | 859,444 | 21.63% |
06-24-2024 | $2.55 | $2.61 | $2.67 | $2.55 | 4,307,964 | 1,236,434 | 28.7% |
06-21-2024 | $2.45 | $2.55 | $2.57 | $2.355 | 10,124,903 | 1,223,195 | 12.08% |
News, Short Squeeze, Breakout and More Instantly...
Allogene Therapeutics Inc. Company Name:
ALLO Stock Symbol:
NASDAQ Market:
Allogene Therapeutics Inc. Website:
Patient Screening is Underway at Rocky Mountain Cancer Centers, Part of the US Oncology Network and Sarah Cannon Research Institute; Astera Cancer Care, Part of the OneOncology Network; and Norton Cancer Institute ALPHA3 Will be the First Pivotal Trial to Offer CAR T as Part of First Line (...
SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced it will participate in th...
SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the pricing of an underwr...